Rickettsial Diagnosis
Diagnose rickettsial infections using PCR on whole blood (3-5 mL EDTA-anticoagulated) during the acute phase (first week of illness, ideally before or within 48 hours of starting doxycycline), combined with paired acute and convalescent serology (IFA) collected 2-4 weeks apart to confirm a fourfold or greater antibody titer rise. 1
Diagnostic Approach by Clinical Stage
Acute Phase (Active Illness - First Week)
Optimal specimens and tests:
Whole blood PCR (preferred): Collect 3-5 mL EDTA-anticoagulated blood for PCR testing of Anaplasma, Ehrlichia, and spotted fever group (SFG) rickettsiae. This is most sensitive during the first week and before or within 48 hours of doxycycline therapy—sensitivity drops rapidly after one week 1
Eschar biopsy/swab (when present): For SFG rickettsiae, eschars contain abundant organisms and represent the best clinical sample for specific diagnosis. A punch biopsy (≥4 mm) of eschar or rash is optimal; alternatively, swab an unroofed eschar (less invasive but less sensitive) 1
Blood smear: Can provide rapid presumptive diagnosis for Anaplasma and Ehrlichia (look for morulae), but sensitivity is low and requires an experienced microscopist 1
Acute serum: Collect 3-5 mL for IFA testing, but recognize that antibodies are often absent during the first week—this acute specimen serves as a baseline for comparison with convalescent serum 1
Convalescent Phase (2-4 Weeks After Illness Onset)
Convalescent serum IFA: Collect 3-5 mL serum for IgG IFA testing. Confirmation requires a fourfold or greater increase in antibody titer between acute and convalescent specimens in patients with clinically compatible illness 1
A single elevated titer (≥64) supports but does not confirm acute infection—serial titers are mandatory for confirmation 1
Critical Diagnostic Pitfalls
Timing is everything:
- IFA serology is insensitive during the first week when most patients present—this is precisely when PCR is most valuable 1
- PCR sensitivity diminishes within one week after collection and after doxycycline initiation 1
- Some species (R. africae) may not show seroconversion until 4 weeks after onset 1
Common errors to avoid:
- Never rely on a single elevated antibody titer to confirm acute infection—this is insufficient and may represent prior exposure 1
- Serum PCR is less sensitive than whole blood PCR; use serum only if whole blood is unavailable 1
- The Weil-Felix test has numerous disadvantages and provides false-positive results, especially where scrub typhus and spotted fever coexist—it should not be used 2, 3
- Early doxycycline therapy may diminish or delay antibody development, but this should not dissuade appropriate serologic testing 1
Disease-Specific Testing Recommendations
Per CDC guidelines 1:
| Disease | Whole Blood PCR | Eschar Biopsy/Swab | Rash Biopsy | Blood Smear (Morulae) | Paired IFA |
|---|---|---|---|---|---|
| Rocky Mountain spotted fever | Yes | — | Yes | — | Yes |
| Rickettsia parkeri rickettsiosis | — | Yes | Yes | — | Yes |
| Ehrlichiosis (E. chaffeensis, E. ewingii) | Yes | — | — | Yes | Yes |
| Anaplasmosis | Yes | — | — | Yes | Yes |
Practical Algorithm
- Suspect rickettsial disease? → Collect acute serum AND whole blood (EDTA) immediately
- Eschar present? → Biopsy or swab for PCR (highest yield for SFG rickettsiae) 1
- First week of illness? → Prioritize PCR (whole blood or tissue); start doxycycline empirically
- Beyond first week? → PCR sensitivity drops; serology becomes more useful
- Always collect convalescent serum at 2-4 weeks for paired IFA testing 1
Emerging Diagnostic Considerations
While the 2016 CDC guidelines [1-1] remain the authoritative framework, recent research highlights that multiplex PCR and point-of-care rapid diagnostic tests are evolving 4, 3. However, these are not yet standard of care. The diagnostic paradigm is shifting from sole reliance on retrospective serology toward integrating nucleic acid amplification with refined serological tests to expand the diagnostic window toward early infection 4, 5, 3.
Culture remains the microbiological reference standard but requires ≥10 days, BSL-3 facilities, and is restricted to reference laboratories—it is not practical for routine clinical diagnosis 1.